| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W H Reid, V A Pham, W Rag. Clozapine use by state programs: public mental health systems respond to a new medication. Hospital & community psychiatry. vol 44. issue 8. 1993-10-21. PMID:8375833. |
several arguments support the use of clozapine in state mental health systems: it is the most effective or only effective medication for many patients, it can decrease the enormous costs of schizophrenia and related disorders, and access to the medication has become an important issue for advocacy groups and other mental health activists. |
1993-10-21 |
2023-08-12 |
Not clear |
| M Kotcher, T E Smit. Three phases of clozapine treatment and phase-specific issues for patients and families. Hospital & community psychiatry. vol 44. issue 8. 1993-10-21. PMID:8375834. |
phase-specific responses of patients and their families during clozapine trials often resemble their reactions during adaptation to chronic schizophrenia. |
1993-10-21 |
2023-08-12 |
Not clear |
| J Volavka, J M Zito, J Vitrai, P Czoba. Clozapine effects on hostility and aggression in schizophrenia. Journal of clinical psychopharmacology. vol 13. issue 4. 1993-10-21. PMID:8376618. |
clozapine effects on hostility and aggression in schizophrenia. |
1993-10-21 |
2023-08-12 |
Not clear |
| M Avnon, I Stolerma. Clozapine, cancer, and schizophrenia. The American journal of psychiatry. vol 150. issue 10. 1993-10-21. PMID:8379568. |
clozapine, cancer, and schizophrenia. |
1993-10-21 |
2023-08-12 |
Not clear |
| T P Zahn, D Picka. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Biological psychiatry. vol 34. issue 1-2. 1993-10-15. PMID:8104043. |
autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. |
1993-10-15 |
2023-08-12 |
Not clear |
| K Kuoppasalmi, R Rimon, H Naukkarinen, S Lang, A Sandqvist, E Leinone. The use of clozapine in treatment-refractory schizophrenia. Schizophrenia research. vol 10. issue 1. 1993-10-14. PMID:8369229. |
the use of clozapine in treatment-refractory schizophrenia. |
1993-10-14 |
2023-08-12 |
Not clear |
| K Kuoppasalmi, R Rimon, H Naukkarinen, S Lang, A Sandqvist, E Leinone. The use of clozapine in treatment-refractory schizophrenia. Schizophrenia research. vol 10. issue 1. 1993-10-14. PMID:8369229. |
the effects of clozapine on positive and negative symptoms were studied in 103 patients with treatment-refractory schizophrenia. |
1993-10-14 |
2023-08-12 |
Not clear |
| R Smith, M Sukowatey, K Solko, J Christensen, J Saak, A Burnha. Clozapine shows promise in schizophrenia treatment. Iowa medicine : journal of the Iowa Medical Society. vol 83. issue 7. 1993-10-07. PMID:8365868. |
clozapine shows promise in schizophrenia treatment. |
1993-10-07 |
2023-08-12 |
Not clear |
| R Smith, M Sukowatey, K Solko, J Christensen, J Saak, A Burnha. Clozapine shows promise in schizophrenia treatment. Iowa medicine : journal of the Iowa Medical Society. vol 83. issue 7. 1993-10-07. PMID:8365868. |
clozapine represents the first significant advance in the pharmacotherapy of schizophrenia since development of phenothiazine antipsychotic drugs in the 1950s and 60s, yet only about 10% of potential patients nationwide are taking the medication. |
1993-10-07 |
2023-08-12 |
Not clear |
| R S Kah. [Effect of clozapine in schizophrenia; starting points for current pharmacotherapeutics]. Nederlands tijdschrift voor geneeskunde. vol 137. issue 29. 1993-09-30. PMID:8361554. |
[effect of clozapine in schizophrenia; starting points for current pharmacotherapeutics]. |
1993-09-30 |
2023-08-12 |
Not clear |
| D B Menke. Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective. BMJ (Clinical research ed.). vol 307. issue 6897. 1993-09-09. PMID:7688254. |
clozapine in the management of schizophrenia. |
1993-09-09 |
2023-08-12 |
Not clear |
| J D Wilso. Clozapine in the management of schizophrenia. Compliance no worse than with other neuroleptic drugs. BMJ (Clinical research ed.). vol 307. issue 6897. 1993-09-09. PMID:8102075. |
clozapine in the management of schizophrenia. |
1993-09-09 |
2023-08-12 |
Not clear |
| S M Dursun, M A Revele. Clozapine in the management of schizophrenia. Clozapine has unique pharmacological profile. BMJ (Clinical research ed.). vol 307. issue 6897. 1993-09-09. PMID:8240510. |
clozapine in the management of schizophrenia. |
1993-09-09 |
2023-08-12 |
Not clear |
| R Kerwin, F Loft. Clozapine in the management of schizophrenia. All schizophrenic patients would benefit. BMJ (Clinical research ed.). vol 307. issue 6897. 1993-09-09. PMID:8343758. |
clozapine in the management of schizophrenia. |
1993-09-09 |
2023-08-12 |
Not clear |
| R R Owen, R Gutierrez-Esteinou, J Hsiao, K Hadd, C Benkelfat, B A Lawlor, D L Murphy, D Picka. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. Archives of general psychiatry. vol 50. issue 8. 1993-08-27. PMID:8343034. |
effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. |
1993-08-27 |
2023-08-12 |
Not clear |
| H Y Meltze. New drugs for the treatment of schizophrenia. The Psychiatric clinics of North America. vol 16. issue 2. 1993-08-19. PMID:8101373. |
clozapine is a great advance in the treatment of schizophrenia. |
1993-08-19 |
2023-08-12 |
Not clear |
| H Y Meltze. New drugs for the treatment of schizophrenia. The Psychiatric clinics of North America. vol 16. issue 2. 1993-08-19. PMID:8101373. |
if progress is made in controlling its agranulocytosis, clozapine could be the drug of choice for all types of schizophrenia and perhaps other conditions as well for which neuroleptic drugs are employed, e.g., mania resistant to mood stabilizers. |
1993-08-19 |
2023-08-12 |
Not clear |
| P J Spector, L A Ople. Schizophrenia and clozapine treatment. The American journal of psychiatry. vol 150. issue 8. 1993-08-12. PMID:8328576. |
schizophrenia and clozapine treatment. |
1993-08-12 |
2023-08-12 |
Not clear |
| S R Hirsch, B K Pur. Clozapine: progress in treating refractory schizophrenia. BMJ (Clinical research ed.). vol 306. issue 6890. 1993-07-29. PMID:8518636. |
clozapine: progress in treating refractory schizophrenia. |
1993-07-29 |
2023-08-12 |
Not clear |
| J M Alvir, J A Lieberman, A Z Safferman, J L Schwimmer, J A Schaa. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. The New England journal of medicine. vol 329. issue 3. 1993-07-22. PMID:8515788. |
clozapine is an atypical antipsychotic agent that is more effective than standard neuroleptic drugs in the treatment of patients with refractory schizophrenia. |
1993-07-22 |
2023-08-12 |
Not clear |